CARE at a glance
Carter Bankshares, Inc. (CARE, SEC CIK 1829576) filed its latest 10-K annual report on March 5, 2026, a 10-Q quarterly report on November 5, 2026, an 8-K current report on November 12, 2026 and Form 4 insider filings as recently as November 13, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), Carter Bankshares, Inc. (CARE) reported revenue of $20.3 million (up 4.6% from FY2024) and net income of $31.4 million. Diluted EPS was $1.38.
- As of September 30, 2026, 29 institutional investment managers tracked by SignalX reported holding Carter Bankshares, Inc. (CARE) shares worth $226.3 million in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by Midkiff Catharine L. on September 11, 2026 of 1,000 shares at $31.25 per share.
- In the last 90 days, CARE insiders reported 0 open-market purchases ($0) and 1 open-market sale ($31K) on Form 4, a net sale of $31K.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $20.3M
- +4.6% vs prior year
- Insiders · 90 days
- 0 buys · 1 sell
- Net −$31K
- 13F holders
- 29 funds
- $226.3M · +1 vs prior quarter
- Latest 8-K
- Nov 12, 2026
- Item 8.01
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Sep 30, 2026
Risk Factors
- No material changes: risk factors unchanged from the December 31, 2025 Form 10-K
Management Discussion & Analysis
- Net interest income $41.2M, up 22.3% YoY from $33.7M
- Net interest margin 3.51% vs 2.86% YoY, with asset yield 5.33% vs 5.03%
- Best segment: commercial real estate, $2.17B loans and 5.93% yield
- Worst credit trend: commercial and industrial, $8.0M charge-off and nonperforming loans $5.96M
- Cash and equivalents $101.7M, down $3.4M; FHLB borrowings down $158.5M to $20.0M
- Near-term strategy: organic loan growth, Carolinas expansion and SBA lending, with CRE and economic conditions as headwinds
AI summary of the CARE 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 8.01: Other Events
- Board authorization for up to $10 million in common-stock repurchases over 12 months
- Program remains subject to non-objection from the Federal Reserve Bank of Richmond
Item 7.01: Regulation FD Disclosure
- Investor presentation furnished for management discussions with investors, analysts and other stakeholders
- Presentation contains Carter Bankshares financial data and is available as Exhibit 99.1 and on carterbank.com
Item EX-99.1: Item EX-99.1
- 3Q 2026 net income $7.8M, up $2.3M year over year but down $21.2M sequentially, reflecting volatile noninterest income
- Net interest income rose $7.5M year over year to $41.2M, with NIM increasing to 3.55% from 2.87%
Item 2.02: Results of Operations and Financial Condition
- Third-quarter and nine-month fiscal 2026 results announced for periods ended September 30, 2026
- Investor-relevant financial metrics and management commentary contained in Exhibit 99.1
Item EX-99.1: Item EX-99.1
- Q3 net income $7.8M, diluted EPS $0.35, sharply below Q2’s $28.9M and $1.31 due to nonrecurring transaction gains
- Net interest income $41.2M, up 22.3% year over year, with net interest margin expanding to 3.51%
AI summaries of CARE 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for CARE
Don't miss the next CARE filing
- Alerts as it files. A push when CARE files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut CARE, by share count.
- Ask anything. An AI agent that reads every CARE filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Walsh Elizabeth L. | J | Nov 13, 2026 | 367,771 | - |
| Walsh Elizabeth L. | J | Nov 13, 2026 | 47,810 | - |
| Midkiff Catharine L. | Sell | Sep 11, 2026 | 1,000 | $31.25 |
| FELDMANN GREGORY W | G | Aug 4, 2026 | 280 | $35.16 |
| Bolton Robert M. | Sell | Jul 30, 2026 | 1,500 | $34.60 |
| Langs Bradford N. | Sell | Jul 30, 2026 | 2,500 | $34.54 |
| Adams Arthur Loran | A | Jun 30, 2026 | 3,240 | - |
| Langs Bradford N. | A | Jun 30, 2026 | 8,649 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | $17.3M | $19.4M | $20.3M |
| Net Income | $23.4M | $24.5M | $31.4M |
| Net Margin | 135.4% | 126.3% | 154.4% |
| Balance Sheet | |||
| Total Assets | $4.5B | $4.7B | $4.9B |
| Equity | - | $384.3M | $419.7M |
| ROE | - | 6.4% | 7.5% |
| Per Share | |||
| EPS | $1.00 | $1.06 | $1.38 |
| Cash Flow | |||
| Operating CF | $46.7M | $36.9M | $39.9M |
| CapEx | $9.8M | $8.1M | $8.1M |
Source: XBRL data in Carter Bankshares, Inc. (CARE)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate CARE share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 29 | $226.3M |
| Q2 2026 | 28 | $245.1M |
| Q1 2026 | 28 | $136.5M |
| Q4 2025 | 26 | $113.0M |
| Q3 2025 | 27 | $115.7M |
| Q2 2025 | 27 | $104.1M |
| Q1 2025 | 23 | $69.0M |
| Q4 2024 | 19 | $65.0M |
- BlackRock+236.3K (+13%)
- Citadel Advisors LLC+110.0K (+447%)
- Dimensional Fund Advisors+108.1K (+9%)
- Citigroup+64.7K (+222%)
- State Street Corp+43.3K (+5%)
- AQR Capital Management−64.3K (-21%)
- Bank of America Corp−28.7K (-27%)
- D.E. Shaw & Co−21.6K (-64%)
- Goldman Sachs Group−21.0K (-6%)
- Ameriprise Financial−8.2K (-14%)
- Principal Financial Group+103.9K
- Raymond James Financial+8.4K
- Mangrove Partners+7.6K
- FMR LLC (Fidelity)−154.1K
- Two Sigma Investments−106.6K
Source: 13F-HR filings on SEC EDGAR (aggregated from 207 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
CARE filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Nov 13, 2026 | - | - | - |
| 8-K | Nov 12, 2026 | - | Analysis | - |
| 10-Q | Nov 5, 2026 | Sep 30, 2026 | Analysis | |
| 8-K | Nov 3, 2026 | - | Analysis | - |
| 8-K | Oct 29, 2026 | - | Analysis | - |
| 8-K | Oct 29, 2026 | - | Analysis | - |
| 4 | Sep 11, 2026 | - | - | - |
| 4 | Sep 11, 2026 | - | - | - |
| 8-K | Aug 17, 2026 | - | Analysis | - |
| 8-K | Aug 11, 2026 | - | Analysis | - |
| 10-Q | Aug 6, 2026 | Jun 30, 2026 | Analysis | |
| 4 | Aug 5, 2026 | - | - | - |
| 4 | Jul 30, 2026 | - | - | - |
| 4 | Jul 30, 2026 | - | - | - |
| 8-K | Jul 27, 2026 | - | Analysis | - |
| 8-K | Jul 23, 2026 | - | Analysis | - |
| 8-K | Jul 23, 2026 | - | Analysis | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 8-K | Jun 24, 2026 | - | Analysis | - |
Related Financials companies
- ALRS · ALERUS FINANCIAL CORPNational Commercial Banks
- AMTB · Amerant Bancorp Inc.National Commercial Banks
- ATLO · AMES NATIONAL CORPNational Commercial Banks
- AROW · ARROW FINANCIAL CORPNational Commercial Banks
- BANC · BANC OF CALIFORNIA, INC.National Commercial Banks
- BANF · BANCFIRST CORP /OK/National Commercial Banks
- TBBK · Bancorp, Inc.National Commercial Banks
- BFC · Bank First CorpNational Commercial Banks
CARE SEC filings: frequently asked questions
Are CARE insiders buying or selling?
In the last 90 days, Carter Bankshares, Inc. (CARE) officers, directors and 10% owners reported no open-market purchases and 1 open-market sale worth $31,250 by 1 insider on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold CARE stock?
As of September 30, 2026, the largest Carter Bankshares, Inc. (CARE) holders among the 13F filers tracked by SignalX were BlackRock ($60.8 million), Dimensional Fund Advisors ($40.8 million), State Street Corp ($28.6 million), Vanguard Capital Management LLC ($28.3 million), Goldman Sachs Group ($10.5 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was CARE's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), Carter Bankshares, Inc. (CARE) reported revenue of $20.3 million (up 4.6% from FY2024) and net income of $31.4 million. Diluted EPS was $1.38. The figures come from the XBRL data in the 10-K.
What did CARE report in its latest 8-K?
Carter Bankshares, Inc. (CARE) filed an 8-K on November 12, 2026 reporting Item 8.01 (Other Events). Board authorization for up to $10 million in common-stock repurchases over 12 months.
What are the latest CARE SEC filings?
Carter Bankshares, Inc. (CARE) filed its latest 10-K annual report on March 5, 2026, a 10-Q quarterly report on November 5, 2026, an 8-K current report on November 12, 2026 and a Form 4 insider filing on November 13, 2026.
What is CARE's SEC CIK number?
Carter Bankshares, Inc. (CARE)'s SEC Central Index Key (CIK) is 1829576. EDGAR lists every CARE filing under that number.
Ask anything about CARE
The research agent reads CARE's filings, financials, insider trades and 13F holders, then answers with sources.